Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sachiko Miyahara

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Statistics in Medicine|August 28, 2010
Weighted Kaplan-Meier estimators for two-stage treatment regimesSachiko Miyahara, Abdus S Wahed
Statistics in Medicine|October 26, 2020
A framework for considering the risk-benefit trade-off in designing noninferiority trials using composite outcome approachesGrace Montepiedra, Ritesh Ramchandani, Sachiko Miyahara, et al.
Brain and Behavior|July 27, 2018
Similar changes in neuropsychological functioning in english and spanish speaking HIV patientsOnoja Akpa, Sachiko Miyahara, Babafemi Taiwo, et al.
Psychiatry Research|July 19, 2005
Perceived criticism from family members as a predictor of the one-year course of bipolar disorderDavid J Miklowitz, Stephen R Wisniewski, Sachiko Miyahara, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 4, 2006
Prediction of psychosis onset in Alzheimer disease: The role of cognitive impairment, depressive symptoms, and further evidence for psychosis subtypesPatricia A Wilkosz, Sachiko Miyahara, Oscar L Lopez, et al.
Journal of Neurovirology|August 31, 2019
Limited correlation between systemic biomarkers and neurocognitive performance before and during HIV treatmentKevin Robertson, Alan Landay, Sachiko Miyahara, et al.
Biological Psychiatry|October 4, 2005
Revisiting depressive-prone bipolar disorder: polarity of initial mood episode and disease course among bipolar I systematic treatment enhancement program for bipolar disorder participantsRoy H Perlis, Melissa P Delbello, Sachiko Miyahara, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2019
Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical TrialsSachiko Miyahara, Ritesh Ramchandani, Soyeon Kim, et al.
Psychiatric Services (Washington, D.C.)|May 6, 2006
Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD ParticipantsS Nassir Ghaemi, Douglas J Hsu, Michael E Thase, et al.
Depression and Anxiety|December 8, 2011
What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?Jackie K Gollan, Maurizio Fava, Benji Kurian, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Statistics in Medicine|August 28, 2010
Weighted Kaplan-Meier estimators for two-stage treatment regimesSachiko Miyahara, Abdus S Wahed
Statistics in Medicine|October 26, 2020
A framework for considering the risk-benefit trade-off in designing noninferiority trials using composite outcome approachesGrace Montepiedra, Ritesh Ramchandani, Sachiko Miyahara, et al.
Brain and Behavior|July 27, 2018
Similar changes in neuropsychological functioning in english and spanish speaking HIV patientsOnoja Akpa, Sachiko Miyahara, Babafemi Taiwo, et al.
Psychiatry Research|July 19, 2005
Perceived criticism from family members as a predictor of the one-year course of bipolar disorderDavid J Miklowitz, Stephen R Wisniewski, Sachiko Miyahara, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 4, 2006
Prediction of psychosis onset in Alzheimer disease: The role of cognitive impairment, depressive symptoms, and further evidence for psychosis subtypesPatricia A Wilkosz, Sachiko Miyahara, Oscar L Lopez, et al.
Journal of Neurovirology|August 31, 2019
Limited correlation between systemic biomarkers and neurocognitive performance before and during HIV treatmentKevin Robertson, Alan Landay, Sachiko Miyahara, et al.
Biological Psychiatry|October 4, 2005
Revisiting depressive-prone bipolar disorder: polarity of initial mood episode and disease course among bipolar I systematic treatment enhancement program for bipolar disorder participantsRoy H Perlis, Melissa P Delbello, Sachiko Miyahara, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2019
Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical TrialsSachiko Miyahara, Ritesh Ramchandani, Soyeon Kim, et al.
Psychiatric Services (Washington, D.C.)|May 6, 2006
Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD ParticipantsS Nassir Ghaemi, Douglas J Hsu, Michael E Thase, et al.
Depression and Anxiety|December 8, 2011
What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?Jackie K Gollan, Maurizio Fava, Benji Kurian, et al.
Pageof 5